North Star Investment Management’s Idexx Laboratories IDXX Stock Holding History

North Star Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Buy	2 +1	+100%	+$561	﹤0.01%	1533
2026 Q1	$562	Sell	1 -2	-67%	-$1.28K	﹤0.01%	1576
2025 Q4	$2.03K	Buy	+3	New	+$2.04K	﹤0.01%	1331
2024 Q2	–	Sell	-4	Closed	-$2.16K	–	1202
2024 Q1	$2.16K	Hold	4	–	–	﹤0.01%	1081
2023 Q4	$2.22K	Hold	4	–	–	﹤0.01%	1039
2023 Q3	$1.75K	Hold	4	–	–	﹤0.01%	1075
2023 Q2	$2.01K	Hold	4	–	–	﹤0.01%	1070
2023 Q1	$2K	Hold	4	–	–	﹤0.01%	1084
2022 Q4	$1.63K	Buy	+4	New	+$1.55K	﹤0.01%	1101
2017 Q3	–	Sell	-270	Closed	-$44K	–	1104
2017 Q2	$44K	Buy	270 +10	+4%	+$1.62K	0.01%	563
2017 Q1	$40K	Hold	260	–	–	0.01%	558
2016 Q4	$30K	Buy	+260	New	+$29.7K	﹤0.01%	571

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

North Star Investment Management's IDXX Position: Q2 2026 in Review

North Star Investment Management increased its Idexx Laboratories (IDXX) stake by 100% in Q2 2026, buying an estimated $561 and bringing the position to 2 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1533.

North Star Investment Management first reported a position in IDXX in Q4 2016 and has held it in 12 quarters since. The position peaked at $44K in Q2 2017. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

North Star Investment Management held 2 shares of Idexx Laboratories worth $1.05K as of Q2 2026.
North Star Investment Management bought 1 Idexx Laboratories share in Q2 2026, an estimated $561.
Idexx Laboratories made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1533 holding.
North Star Investment Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 12 quarters since.
North Star Investment Management's Idexx Laboratories position peaked at $44K in Q2 2017.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.